Today Pharmacovigilance has gone through what some would call a revolution. That’s due in large part to the technology that companies are implementing within their safety systems. Many companies are assessing their case intake system. We at Astrix are assisting many companies with their projects and whether it’s helping them with their RFP’s, or with their implementations. The most common questions that we hear when assisting companies is: What are the features and functionalities that we should have or expect the tool to be able to do and how’s it going to help me? How is it going to make my ..read more

Astrix had the opportunity on Oct 4-5 to participate as a Gold Sponsor of the World Drug Safety Congress conference in Boston, MA. This event had over 1000+ pharmacovigilance and safety experts in attendance. The list included pharma and biotech companies, along with academic, government, regulators, and vendors who came together to discuss the key challenges being faced in the PV world. Participants from Astrix included individuals from our PV Delivery Services, Strategic Consulting Services, and Marketing organizations. At this event, Astrix had the opportunity to meet many existing and ..read more

Today Pharmacovigilance has gone through what some would call a revolution. That’s due in large part to the technology that companies are implementing within their safety systems. Many companies are assessing their case intake system. We at Astrix are assisting many companies with their projects and whether it’s helping them with their RFP’s, or with their implementations. The most common questions that we hear when assisting companies is: What are the features and functionalities that we should have or expect the tool to be able to do and how’s it going to help me? How is it going to make my ..read more

Today Pharmacovigilance has gone through what some would call a revolution. That’s due in large part to the technology that companies are implementing within their safety systems. Many companies are assessing their case intake system. We at Astrix are assisting many companies with their projects and whether it’s helping them with their RFP’s, or with their implementations. The most common questions that we hear when assisting companies is: What are the features and functionalities that we should have or expect the tool to be able to do and how’s it going to help me? How is it going to make my ..read more

Today Pharmacovigilance has gone through what some would call a revolution. That’s due in large part due to the technology that vendors are implementing within their safety systems. Many companies are assessing their case intake system. We at Astrix are assisting many companies with their projects and whether it’s helping them with their RFP’s, or with their implementations, the most common questions that we hear when assisting companies are: What are the features and functionalities that we should have or expect the tool to be able to do? How is it going to make my processes more efficient ..read more

In today’s ever changing Pharmacovigilance system organizations, companies often find themselves in a situation where it is advantageous to upgrade their pharmacovigilance system by migrating data from legacy systems into a new or even existing system.  A data migration project will often involve the use of ETL technology to assist. Migrating data to a pharmacovigilance system can be a challenging endeavor, however, companies often have years of historical data and knowledge stored in their existing pharmacovigilance system that must be migrated over to the chosen system. Depending on the ..read more

Your safety program will be impacted by the system and provider you choose for years to come. Although system functionality frequently predominates in selection criteria, we have learned to consider key attributes of each candidate system vendor as early in the selection process as possible before selecting the best fit. Astrix has direct experience working with clients to help them choose their system providers. This experience, along with our Pharmacovigilance System Providers neutrality and lack of financial interest policies, allows us to provide insights to help you throughout the entire ..read more

The Intake process and its corresponding tools have been a point of focus for companies updating their safety systems because the Case Intake (Initial Triage) Workflow phase can take up to 50% of the overall case processing time. Current and new vendors are focusing on incorporating modern technology into their Intake tools to gain efficiency in this portion of the process. Sometimes, however, these modern technologies manifest themselves as features, functionalities, or post-implementation options that can distract, complicate, or unexpectedly impact budgets for new and upgraded safety system ..read more

Artificial Intelligence (“AI”) and Machine Learning (“ML”) are creating a buzz in the Pharmacovigilance (“PV”) space because of their transformative potential to provide new and interesting insights, by processing big data in a timely, accurate, and cost-efficient manner, and promises to enable product innovations to better protect patients and the world. Defining Terms Artificial Intelligence is a becoming challenging term to pin down because, increasingly, it’s applied across an exploding array of new approaches, applications, and products, but I like to think of it as, “The ability to train ..read more

Astrix had the opportunity on Oct 4-5 to participate as a Gold Sponsor of the World Drug Safety Congress conference in Boston, MA. This event had over 1000+ pharmacovigilance and safety experts in attendance. The list included pharma and biotech companies, along with academic, government, regulators, and vendors who came together to discuss the key challenges being faced in the PV world. Participants from Astrix included individuals from our PV Delivery Services, Strategic Consulting Services, and Marketing organizations. At this event, Astrix had the opportunity to meet many existing and ..read more